The present findings show that VEGFR2 upregulation in the kidney of HFD-treated mice promotes ROS overproduction, consequently induces NLRP3-dependent inflammatory responses, and ultimately leads to kidney damage. The gene discussed is NLRP3; the disease is Nephropathy.